Pedro Cahn

18.6k total citations · 4 hit papers
217 papers, 9.3k citations indexed

About

Pedro Cahn is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Pedro Cahn has authored 217 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Infectious Diseases, 120 papers in Virology and 72 papers in Epidemiology. Recurrent topics in Pedro Cahn's work include HIV/AIDS Research and Interventions (128 papers), HIV Research and Treatment (120 papers) and HIV/AIDS drug development and treatment (106 papers). Pedro Cahn is often cited by papers focused on HIV/AIDS Research and Interventions (128 papers), HIV Research and Treatment (120 papers) and HIV/AIDS drug development and treatment (106 papers). Pedro Cahn collaborates with scholars based in Argentina, United States and Brazil. Pedro Cahn's co-authors include Peter Reiss, Donna M. Jacobsen, Paul A. Volberding, Melanie Thompson, Douglas D. Richman, Scott M. Hammer, Joseph J. Eron, Margaret A. Fischl, José M. Gatell and Sharon Walmsley and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Pedro Cahn

211 papers receiving 9.0k citations

Hit Papers

Antiretroviral Treatment of Adult HIV Infection 2008 2026 2014 2020 2012 2008 2010 2014 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Antiretroviral Treatment of Adult HIV Infection
    2012 1.4k citations Pedro Cahn et al. profile →
  2. Antiretroviral Treatment of Adult HIV Infection
    2008 832 citations Pedro Cahn et al. profile →
  3. Antiretroviral Treatment of Adult HIV Infection
    2010 595 citations Pedro Cahn et al. profile →
  4. Antiretroviral Treatment of Adult HIV Infection
    2014 352 citations Pedro Cahn et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pedro Cahn Argentina 46 7.4k 5.2k 2.6k 2.0k 626 217 9.3k
Anton Pozniak United Kingdom 53 8.2k 1.1× 5.2k 1.0× 3.5k 1.4× 1.9k 0.9× 747 1.2× 294 10.7k
Donna M. Jacobsen United States 22 9.1k 1.2× 7.0k 1.3× 2.6k 1.0× 1.8k 0.9× 665 1.1× 33 10.6k
Richard Haubrich United States 47 6.5k 0.9× 4.9k 0.9× 2.2k 0.9× 1.6k 0.8× 444 0.7× 184 8.8k
Alexandra Calmy Switzerland 53 6.5k 0.9× 3.8k 0.7× 3.2k 1.2× 3.3k 1.6× 801 1.3× 305 10.1k
Sharon Walmsley Canada 47 6.6k 0.9× 4.2k 0.8× 4.0k 1.5× 1.9k 0.9× 825 1.3× 331 10.8k
Melanie Thompson United States 46 10.4k 1.4× 7.4k 1.4× 3.6k 1.4× 2.5k 1.2× 891 1.4× 112 12.9k
Jack Fuhrer United States 19 6.2k 0.8× 4.2k 0.8× 3.4k 1.3× 2.5k 1.2× 534 0.9× 33 9.3k
Judith A. Aberg United States 51 5.9k 0.8× 2.5k 0.5× 3.0k 1.2× 2.9k 1.4× 543 0.9× 200 9.2k
Diane Aschman United States 7 5.7k 0.8× 3.8k 0.7× 2.9k 1.1× 2.0k 1.0× 445 0.7× 12 7.8k
Matthias Cavassini Switzerland 58 7.8k 1.0× 5.0k 0.9× 3.7k 1.4× 3.0k 1.5× 1.1k 1.8× 367 11.8k

Countries citing papers authored by Pedro Cahn

Since Specialization
Citations

This map shows the geographic impact of Pedro Cahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Cahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Cahn more than expected).

Fields of papers citing papers by Pedro Cahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Cahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Cahn. The network helps show where Pedro Cahn may publish in the future.

Co-authorship network of co-authors of Pedro Cahn

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro Cahn. A scholar is included among the top collaborators of Pedro Cahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro Cahn. Pedro Cahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lacunza, Ezequiel, Valeria Fink, Siôn L. Williams, et al.. (2023). Oral and anal microbiome from HIV-exposed individuals: role of host-associated factors in taxa composition and metabolic pathways. npj Biofilms and Microbiomes. 9(1). 48–48. 8 indexed citations
3.
Sued, Omar, Diego Cecchini, María José Rolón, et al.. (2022). A small cluster randomised clinical trial to improve health outcomes among Argentine patients disengaged from HIV care. The Lancet Regional Health - Americas. 13. 100307–100307. 2 indexed citations
4.
Arístegui, Inés, et al.. (2021). Correlates of depressive symptoms in transgender women initiating HIV treatment in Argentina. Journal of Gay & Lesbian Mental Health. 25(2). 208–225. 4 indexed citations
5.
Belaunzarán-Zamudio, Pablo F., Juan Sierra Madero, Jaime Andrade‐Villanueva, et al.. (2020). The effect of protease inhibitor‐based dual antiretroviral regimens on CD4/CD8 ratio during the first year of therapy in ART‐naïve patients with HIV‐infection. HIV Medicine. 22(4). 254–261. 3 indexed citations
6.
7.
Boffito, Marta, Laura Waters, Pedro Cahn, et al.. (2019). Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection. AIDS Research and Human Retroviruses. 36(1). 13–18. 28 indexed citations
8.
Sued, Omar, Yanina Ghiglione, María A. Pando, et al.. (2018). Computational comparison of availability in CTL/gag epitopes among patients with acute and chronic HIV-1 infection. Vaccine. 36(28). 4142–4151. 1 indexed citations
9.
10.
César, Carina, José A. Ruipérez‐Valiente, Peter F. Rebeiro, et al.. (2016). The HIV care cascade in Buenos Aires, Argentina: results in a tertiary referral hospital.. PubMed. 40(6). 448–454. 7 indexed citations
11.
Beyrer, Chris, Deborah L. Birx, Linda‐Gail Bekker, et al.. (2015). The Vancouver Consensus: antiretroviral medicines, medical evidence, and political will. The Lancet. 386(9993). 505–507. 17 indexed citations
12.
Batman, P A, Moses Kapembwa, Liliana Belmonte, et al.. (2013). HIV enteropathy: HAART reduces HIV-induced stem cell hyperproliferation and crypt hypertrophy to normal in jejunal mucosa. Journal of Clinical Pathology. 67(1). 14–18. 9 indexed citations
13.
Cahn, Pedro, et al.. (2012). Preclinical and First-In-Human Phase I Clinical Evaluation of Stampidine, a Potent Anti-HIV Pharmaceutical Drug Candidate. Journal of AIDS & Clinical Research. 3(1). 19 indexed citations
14.
Jurado, Javier O., Virginia Pasquinelli, Ivana B. Alvarez, et al.. (2012). ICOS, SLAM and PD‐1 expression and regulation on T lymphocytes reflect the immune dysregulation in patients with HIV‐related illness with pulmonary tuberculosis. Journal of the International AIDS Society. 15(2). 17428–17428. 11 indexed citations
15.
Cahn, Pedro, Javier Altclas, Maria Isabel Morgan Martins, et al.. (2008). O414 48-week data from Study AVX-201 – a randomised phase IIb study of apricitabine in treatment-experienced patients with M184V and NRTI resistance. Journal of the International AIDS Society. 11(S1). 4 indexed citations
16.
Sáez‐Llorens, Xavier, Richard A. Rode, Edward Handelsman, et al.. (2003). . The Pediatric Infectious Disease Journal. 22(3). 216–223. 5 indexed citations
17.
Sáez‐Llorens, Xavier, Richard A. Rode, Perry Gomez, et al.. (2003). Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children. The Pediatric Infectious Disease Journal. 22(3). 216–223. 102 indexed citations
18.
Zala, Carlos, et al.. (2003). Discrepant results in the interpretation of HIV‐1 drug‐resistance genotypic data among widely used algorithms. HIV Medicine. 4(1). 72–78. 45 indexed citations
19.
Rodero, L, Susana Córdoba, Pedro Cahn, et al.. (2000). Timed-kill curves for Cryptococcus neoformans isolated from patients with AIDS. Medical Mycology. 38(3). 201–207. 25 indexed citations
20.
Quarleri, Jorge, María Belén Bouzas, Natalia Laufer, et al.. (1993). HCV genotype distribution among HIV co-infected individuals in Argentina: relationship with host and viral factors.. TLS, the Times literary supplement/Times literary supplement on CD-ROM/TLS. Times literary supplement. 37(2). 10–83. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anton Pozniak Breakdown of academic impact, for papers by Donna M. Jacobsen Breakdown of academic impact, for papers by Richard Haubrich Breakdown of academic impact, for papers by Alexandra Calmy Breakdown of academic impact, for papers by Sharon Walmsley Breakdown of academic impact, for papers by Melanie Thompson Breakdown of academic impact, for papers by Jack Fuhrer Breakdown of academic impact, for papers by Judith A. Aberg Breakdown of academic impact, for papers by Diane Aschman Breakdown of academic impact, for papers by Matthias Cavassini
Rankless by CCL
2026